Used in biomedical research to detect and quantify advanced glycosylation end products (AGEs) in human biological samples such as serum, plasma, and tissue extracts. This kit is essential for studying the role of AGEs in the progression of chronic diseases including diabetes, cardiovascular disorders, and renal failure. It enables researchers to assess oxidative stress and glycation damage, monitor disease development, and evaluate the effectiveness of therapeutic interventions aimed at reducing AGE accumulation. Commonly used in clinical labs and pharmaceutical research for biomarker analysis and pathophysiological studies.